Acquired Resistance during Short-Course Treatment for Rifampicin-Resistant Tuberculosis
{{output}}
Background: Shorter regimens represent a significant advancement for rifampicin-resistant tuberculosis (RR-TB) treatment. However, data on acquired drug resistance (ADR) remain limited. ... ...
